These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4605471)

  • 1. [A new bronchodilatador, hexoprenaline, in obstructive pulmonary disease (author's transl)].
    van As A; Benjamin C; Stern JD
    Folia Clin Int (Barc); 1974 Jun; 24(6):485-97. PubMed ID: 4605471
    [No Abstract]   [Full Text] [Related]  

  • 2. A new bronchodilator, hexoprenaline, in obstructive pulmonary disease.
    van As A; Benjamin C; Stern JD
    Scand J Respir Dis; 1973; 54(1):28-37. PubMed ID: 4690403
    [No Abstract]   [Full Text] [Related]  

  • 3. Hexoprenaline--a new bronchodilator.
    Vermaak JC; De Kock MA; Joubert JR
    S Afr Med J; 1972 Dec; 46(51):1999-2001. PubMed ID: 4651880
    [No Abstract]   [Full Text] [Related]  

  • 4. [Double blind trial of hexoprenaline as a bronchodilator].
    Ulmer WT
    Arzneimittelforschung; 1974 May; 24(5):840-1. PubMed ID: 4603484
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of the bronchodilating effect of SCH 1000, berotec and of the association of the two drugs in patients with spastic bronchitis (author's transl)].
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1974; 65(5):534-9. PubMed ID: 4282820
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bronchodilator effect of hexoprenalin administered in a dosed aerosol form (spirographic evaluation)].
    Cornudella R; Castellano A; Santafé G
    Rev Clin Esp; 1973 Jun; 129(5):469-76. PubMed ID: 4732991
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutical effect of a new antidyspnoeic drug in the chronic obstructive pulmonary disease (author's transl)].
    Chillón F
    Folia Clin Int (Barc); 1973 Jun; 23(6):464-76. PubMed ID: 4805350
    [No Abstract]   [Full Text] [Related]  

  • 8. [Body plethysmographic investigations with the new bronchodilator NAB365 (author's transl)].
    Kaik G
    MMW Munch Med Wochenschr; 1975 May; 117(22):959-60. PubMed ID: 807812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Can the association of an atropinic (SCH 1000) and a sympathicomimetic improve the bronchodilatation obtained by a sympathicomimetic alone (author's transl)].
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1974; 65(3-4):395-408. PubMed ID: 4282560
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of hexoprenaline on blood pressure].
    Lageder H; Hitzenberger G; Thoma F; Irsigler K
    Int J Clin Pharmacol; 1974 Sep; 10(2):90-4. PubMed ID: 4448556
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of the new brondilatator reproterol on the cardiac function during treatment of bronchial asthma and chronic obstructive bronchitis (author's transl)].
    Zecevic D; Tabori D; Mijatovic S; Todic V; Concic B; Aurich R; Stadler R
    Arzneimittelforschung; 1977; 27(12):53-5. PubMed ID: 576832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of pressure-packed bornchodilator aerosols in chronic obstructive bronchitis.
    Chatterjee SS; Dinda P; Riding WD
    Scand J Respir Dis; 1971; 52(2):71-6. PubMed ID: 5170643
    [No Abstract]   [Full Text] [Related]  

  • 13. The bronchodilator effects of orciprenaline and salbutamol. A double-blind study.
    Racoveanu C; Stanescu DC; Manicatide M; Stroescu V
    Postgrad Med J; 1971 Mar; 47():Suppl:83-6. PubMed ID: 4929399
    [No Abstract]   [Full Text] [Related]  

  • 14. [Testing of the bronchodilator NAB 365 in a double blind trial author's transl].
    Taeger D
    Med Klin; 1975 Jun; 70(24):1052-4. PubMed ID: 1097878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of a new bronchodynamic drug by aerosol administration in asthmatic bronchitis and emphysema patients. Study of the respiratory function].
    Cardaci G; Vittore F; Bussa B
    Clin Ter; 1968 Jun; 44(6):533-41. PubMed ID: 5736873
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study of the effects of isoetharine and some other adrenergic beta-stimulators in chronic obstructive lung disease.
    Thiringer G; Bergh NP; Svedmyr N
    Scand J Respir Dis; 1971; 52(4):183-91. PubMed ID: 5161421
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of 3 beta-mimetic bronchodilators: clenbuterol, hexoprenaline, fenoterol. Comparative study].
    Villate Navarro JI; Sobradillo Peña V; Atxotegui Iraola-Goitia V; Uresandi Romero F; Sánchez García J
    Rev Clin Esp; 1980 Sep; 158(5):215-8. PubMed ID: 7001578
    [No Abstract]   [Full Text] [Related]  

  • 18. [Multicenter clinical study on the delayed use of ipratropium-fenoterol in broncho-obstructive pathology].
    Babich S; Bariffi F; Bisetti A; Carnimeo N; Cavalli A; Corda M; De Michele G; Girbino G; Mancini PA; Melica A
    Arch Monaldi; 1983; 38(5-6):305-16. PubMed ID: 6238585
    [No Abstract]   [Full Text] [Related]  

  • 19. [Guacetisal in the treatment of acute and chronic bronchopneumopathy].
    Carpinteri F; Carosi M
    Minerva Med; 1981 Feb; 72(7):347-53. PubMed ID: 7017484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative assessment of the efficiency of three new bronchodilators (salbutamol, terbutaline, Th 1165 a) in the management of patients with chronic obstructive lung disease.
    Manicatide MA; Racoveanu CL; Nicolaescu VV; Teculescu DB
    Rev Roum Med Intern; 1973; 10(1):49-56. PubMed ID: 4571833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.